Characteristics | Model 1 a | Model 2 |
---|
β | Hazard ratio (95% CI) | P | β | Hazard ratio (95% CI) | P |
---|
Subcohort A |
Hyper-CEA | −0.059 | 0.94 (0.76, 1.18) | 0.602 | −0.116 | 0.89 (0.71, 1.12)b1 | 0.326 |
Norm-CEA | | 1 | | | 1 | |
Subcohort B |
MetS | 0.161 | 1.17 (0.99, 1.40) | 0.07 | 0.016 | 1.02 (0.84, 1.22)b2 | 0.864 |
Non-MetS | | 1 | | | 1 | |
- a: Model 1, crude model without adjusting for any confounders; b1: Model 2 in subcohort A, adjusted for age, smoking, alcohol intake, the components of MetS, blood uric acid, alanine aminotransferase, aspartate aminotransferase, gamma-glutamyl transpeptidase, haemoglobin and white blood cell count; b2: Model 2 in subcohort B, adjusted for age, smoking, alanine aminotransferase, serum creatinine and white blood cell count. CEA Carcinoembryonic antigen; Hyper-CEA Elevated serum CEA level above the reference range; Norm-CEA Within the normal reference ranges; MetS Metabolic syndrome; Non-MetS Without metabolic syndrome